MunsterLab UCSF

Celebrating Dr. Munster's incredible journey at UCSF and biding her farewell at her retirement party. Like we all appreciate, she never does anything half throttle. @UCSFCancer @UCSF

See you at AACR

Happy holidays from Munster lab

Lab lunch before the holiday season begins. We are happy to welcome Emata Alberto to the lab and we wish Scott, a happy birthday

Single-cell spatial multiomics reveals tumor microenvironment vulnerabilities in cancer resistance to immunotherapy dlvr.it/T93wkf

We wish you well, Pujan Desai! Go do great things at UC DAVIS

Immunotherapy is usually ineffective in pancreatic cancer, but this paper shows there's two opportunities to boost the response 1. If the pancreatic cancer is associated with pancreatitis That's shown here - the response to immunotherapy (in mice) is only effective when pancreatic cancer is associated with long-term pancreatitis (LP): 2. The immune environment of pancreatitis can be replicated (in mice) using a vaccine of dendritic cells, loaded with cancer antigens This means that anti-PD1/CTLA4 immunotherapy can be effective, even in the absence of pancreatitis: Mahadevan et al in Science: science.org/doi/10.1126/sc…

Our latest in a series of educational workshops for to provide more information for mutation carriers and family members @UCSF_BRCA. This issue focused on hereditary pancreatic cancer risks, challenges, and recommendations. Click on link below to listen.

Well deserved @s_brond - you are an amazing physician and so dedicated to world wide education! @UCSFCancer @ASCO

Tuesday, April 30th "Colorectal Cancer Risk: What is different for patients with hereditary cancer mutations?" | Join Dr. Pamela Munster @PMunsterMD @UCSFHospitals for the latest @UCSFCancer BRCA and Hereditary Cancer Workshop ow.ly/ziqX50RcK5x

A special evening today: Dr. Pamela Munster gets endowed with Mariam Moghadam Safinia distinguished professorship in hereditary cancer research @UCSFCancer #breastcancer #Oncology #researchers

Dr. Pamela Munster @munsterlab1 delivers an excellent lecture on the balance between efficacy and potential toxicity of the ADC bystander effect. Can we optimize ADCs in a way to take advantage of the bystander effect while minimizing collateral damage? #DAVAVictoriaADCs

Here is the link to the LinkedIn ad linkedin.com/jobs/view/3515…

We are hiring a postdoc, please apply @UCSFCancer @UCSF #postdocjobs #AcademicTwitter #AcademicChatter #clinicaltrials #CancerResearch

We are hiring - please apply linkedin.com/jobs/view/3515…

We are recruiting a postdoc to work at the interface of academia and industry! Please apply on LinkedIn. Here is the job link linkedin.com/jobs/view/2771…

Exciting news from Catalyst Awardee Pamela Munster and Alessa Therapeutics! @UCSF_Catalyst supported @munsterlab1's prostate cancer project with early-stage seed funding and industry advisor mentorship einnews.com/pr_news/537016…

And I hope we soon stop calling TNBC "triple negative" and start referring to what markers subtypes of this subtype do have. #LBBCMetsConf

Have you read our recent review? We review the current advances and research on immunotherapy in breast cancer, particularly immune checkpoint inhibitors, adoptive cell transfer and cancer vaccines @SibapriyaC @bernmunster, Scott Thomas sciencedirect.com/science/articl…

Congratulations @lindsayahampson @UCSFUrology on being selected by @AmerUrological for a 2021 Young Urologist of the Year Award #UCSFProud